medmix Management
Management criteria checks 2/4
medmix's CEO is Girts Cimermans, appointed in Sep 2021, has a tenure of 2.67 years. total yearly compensation is CHF1.77M, comprised of 31.1% salary and 68.9% bonuses, including company stock and options. directly owns 0.017% of the company’s shares, worth CHF114.07K. The average tenure of the management team and the board of directors is 2.7 years and 2.1 years respectively.
Key information
Girts Cimermans
Chief executive officer
CHF1.8m
Total compensation
| CEO salary percentage | 31.1% |
| CEO tenure | 2.7yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2.7yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return
Dec 19
An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued
Oct 27Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital
Aug 16There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings
Feb 28medmix (VTX:MEDX) May Have Issues Allocating Its Capital
Jan 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CHF2m | CHF550k | CHF300k |
| Sep 30 2023 | n/a | n/a | CHF5m |
| Jun 30 2023 | n/a | n/a | CHF10m |
| Mar 31 2023 | n/a | n/a | CHF11m |
| Dec 31 2022 | CHF2m | CHF550k | CHF12m |
| Sep 30 2022 | n/a | n/a | CHF21m |
| Jun 30 2022 | n/a | n/a | CHF31m |
| Mar 31 2022 | n/a | n/a | CHF37m |
| Dec 31 2021 | CHF395k | CHF154k | CHF44m |
Compensation vs Market: Girts's total compensation ($USD1.94M) is above average for companies of similar size in the Swiss market ($USD1.44M).
Compensation vs Earnings: Girts's compensation has been consistent with company performance over the past year.
CEO
Girts Cimermans (54 yo)
2.7yrs
Tenure
CHF1,766,000
Compensation
Mr. Girts Cimermans is Chief Executive Officer at medmix AG since September 2021. He has been President of the Applicator Systems (APS) division of Sulzer Ltd since October 21, 2019 until September 19, 202...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 2.7yrs | CHF1.77m | 0.017% CHF 114.1k | |
| Chief Financial Officer | 2.7yrs | no data | 0.0049% CHF 32.2k | |
| Head of M&A | 2yrs | no data | no data | |
| Chief Legal Officer | no data | no data | 0.0023% CHF 15.5k | |
| Chief Human Resources | no data | no data | no data |
2.7yrs
Average Tenure
54.5yo
Average Age
Experienced Management: MEDX's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 2.1yrs | CHF144.00k | 0.0039% CHF 25.6k | |
| Independent Director | no data | CHF167.00k | 0.11% CHF 743.2k | |
| Director | 2.1yrs | CHF146.00k | 0.0015% CHF 10.1k | |
| Independent Vice Chairman of the Board | 2.7yrs | CHF163.00k | 0.032% CHF 212.5k | |
| Independent Director | 2.1yrs | CHF146.00k | 0.0015% CHF 10.1k | |
| Independent Chairman | 2.1yrs | CHF302.00k | 0.0017% CHF 11.2k | |
| Director | 2.1yrs | CHF146.00k | 0.0015% CHF 10.1k |
2.1yrs
Average Tenure
54yo
Average Age
Experienced Board: MEDX's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.